Segment and Geographic Information

3 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Segment and Geographic Information

Segment and Geographic Information

The Company manages its business and operations as one segment and is focused on advancing the treatment of acute and intensive care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company allocates resources and assesses financial performance on a consolidated basis. Revenues reported to date are derived primarily from sales of Angiomax in the United States.

The geographic segment information provided below is classified based on the major geographic regions in which the Company operates. Long-lived assets are comprised of the Company’s noncurrent assets.

	Three Months Ended March 31,
	2016				2015
	(in thousands)				(in thousands)
Net revenues:
United States	$	46,436	92.3	%	$	104,458	94.9	%
Europe	3,080		6.1	%	4,993		4.5	%
Rest of world	790		1.6	%	664		0.6	%
Total net revenues	$	50,306	100.0	%	$	110,115	100.0	%

	March 31, 2016				December 31, 2015
	(in thousands)				(in thousands)
Long-lived assets:
United States	$	1,027,783	99.4	%	$	956,298	99.3	%
Europe	6,165		0.6	%	6,301		0.7	%
Rest of world	—		—	%	—		—	%
Total long-lived assets	$	1,033,948	100.0	%	$	962,599	100.0	%